Human V-rel avian reticuloendotheliosis viral oncogene related B (RELB) ELISA Kit,Abbkine_specification/price/image

Product Detail
Company Profile

Bours et al. (1994) demonstrated that human RELB, when generated in mammalian cells, formed kappa-B-binding heterodimeric complexes with p50 (NFKB1) or p52 (NFKB2). Homodimeric complexes of RELB did not show DNA-binding activity.NF-kappa-B-inducing kinase (NIK, or MAP3K14) is required for osteoclastogenesis in response to pathologic stimuli. Vaira et al. (2008) found that overexpression of Relb, but not Rela, rescued differentiation of mouse Nik -/- osteoclast precursors, indicating that blockade of the alternative NF-kappa-B pathway, rather than the classical NF-kappa-B pathway, is responsible for the osteoclastogenic defect in the absence of Nik. Using Relb -/- mice, they showed that Relb itself was required for Rankl-induced osteoclastogenesis in vitro and for TNF-induced bone resorption in vivo

Human V-rel avian reticuloendotheliosis viral oncogene related B (RELB) ELISA Kit employs a two-site sandwich ELISA to quantitate RELB in samples. An antibody specific for RELB has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyRELB present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for RELB is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of RELB bound in the initial step. The color development is stopped and the intensity of the color is measured.

Human V-rel avian reticuloendotheliosis viral oncogene related B (RELB) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/human-v-rel-avian-reticuloendotheliosis-viral-oncogene-related-b-relb-elisa-kit-kte60810/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.